Float Short %

4.75

Margin Of Safety %

-19

Put/Call OI Ratio

0.22

EPS Next Q Diff

-0.21

EPS Last/This Y

12.4

EPS This/Next Y

0.29

Price

134.85

Target Price

120.39

Analyst Recom

2.52

Performance Q

33.64

Relative Volume

0.95

Beta

1.42

Ticker: ILMN

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-13	ILMN	119.88	0.29	0.17	93514
2025-11-14	ILMN	120.73	0.30	0.45	93297
2025-11-17	ILMN	120.13	0.29	0.41	93425
2025-11-18	ILMN	122.41	0.29	0.37	93712
2025-11-19	ILMN	120.11	0.29	0.11	93661
2025-11-20	ILMN	119.29	0.29	0.36	93637
2025-11-21	ILMN	123.81	0.29	0.22	93416
2025-11-24	ILMN	125.89	0.21	0.12	76386
2025-11-25	ILMN	129.66	0.21	0.17	78952
2025-11-26	ILMN	129.86	0.21	0.16	79563
2025-12-01	ILMN	128.75	0.21	0.12	79840
2025-12-02	ILMN	127.58	0.21	0.08	79533
2025-12-03	ILMN	128	0.21	0.60	79141
2025-12-04	ILMN	128.07	0.21	0.52	79217
2025-12-05	ILMN	129	0.21	0.68	79238
2025-12-08	ILMN	127.24	0.21	0.54	79745
2025-12-09	ILMN	132.11	0.21	0.41	79840
2025-12-10	ILMN	134.94	0.22	0.30	80278
2025-12-11	ILMN	136.47	0.22	1.06	80323
2025-12-12	ILMN	134.9	0.22	0.16	80527
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-13	ILMN	119.89	42.3	62.3	4.71
2025-11-14	ILMN	120.60	42.3	85.2	4.71
2025-11-17	ILMN	120.10	42.3	74.8	4.71
2025-11-18	ILMN	121.99	42.3	95.6	4.71
2025-11-19	ILMN	120.12	42.3	64.3	4.71
2025-11-20	ILMN	119.21	42.3	72.0	4.71
2025-11-21	ILMN	123.85	42.4	118.3	4.71
2025-11-24	ILMN	125.95	42.4	96.8	4.71
2025-11-25	ILMN	129.64	42.4	109.2	4.71
2025-11-26	ILMN	129.85	42.4	81.4	4.71
2025-12-01	ILMN	128.75	42.4	58.9	4.71
2025-12-02	ILMN	127.55	42.4	70.5	4.71
2025-12-03	ILMN	127.95	42.4	82.9	4.71
2025-12-04	ILMN	128.05	42.4	51.4	4.71
2025-12-05	ILMN	128.96	42.5	57.8	4.71
2025-12-08	ILMN	127.25	42.5	-	4.71
2025-12-09	ILMN	132.13	42.5	88.3	4.71
2025-12-10	ILMN	132.13	42.5	71.4	4.71
2025-12-11	ILMN	136.44	42.5	61.9	4.71
2025-12-12	ILMN	134.85	42.5	39.2	4.71
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-13	ILMN	0.45	-1.07	4.53
2025-11-14	ILMN	0.45	-1.07	4.53
2025-11-17	ILMN	0.01	0.52	4.54
2025-11-18	ILMN	0.01	0.52	4.53
2025-11-19	ILMN	0.01	0.52	4.53
2025-11-20	ILMN	0.01	0.52	4.53
2025-11-21	ILMN	0.01	0.52	4.53
2025-11-24	ILMN	0.01	0.68	4.53
2025-11-25	ILMN	0.01	0.68	4.53
2025-11-26	ILMN	0.01	0.68	4.41
2025-12-01	ILMN	0.01	0.64	4.41
2025-12-02	ILMN	0.01	0.64	4.41
2025-12-03	ILMN	0.01	0.64	4.41
2025-12-04	ILMN	0.01	0.64	4.41
2025-12-05	ILMN	0.01	0.64	4.41
2025-12-08	ILMN	0.01	0.73	4.41
2025-12-09	ILMN	-0.00	0.73	4.41
2025-12-10	ILMN	-0.00	0.73	4.75
2025-12-11	ILMN	-0.00	0.73	4.75
2025-12-12	ILMN	-0.00	0.73	4.75
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ILMN" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

1.34

Avg. EPS Est. Current Quarter

1.23

Avg. EPS Est. Next Quarter

1.13

Insider Transactions

Institutional Transactions

0.73

Beta

1.42

Average Sales Estimate Current Quarter

1102

Average Sales Estimate Next Quarter

1058

Fair Value

109.74

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-86.2

Target Price

120.39

P/E

30.22

Forward P/E

26.91

PEG

2.41

P/S

4.81

P/B

8.67

P/Free Cash Flow

20.61

EPS

4.46

Average EPS Est. Cur. Y

4.71

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.41

Relative Volume

0.95

Return on Equity vs Sector %

2.6

Return on Equity vs Industry %

18.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

39.2

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ILMN” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ILMN” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ILMN” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ILMN” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ILMN” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ILMN” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ILMN” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

Illumina, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 8970

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

stock quote shares ILMN – Illumina, Inc. Stock Price stock today

news today ILMN – Illumina, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ILMN – Illumina, Inc. yahoo finance google finance

stock history ILMN – Illumina, Inc. invest stock market

stock prices ILMN premarket after hours

ticker ILMN fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ILMN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y